FISONS INVESTING $150 MIL. IN NEW MANUFACTURING FACILITY
FISONS INVESTING $150 MIL. IN NEW MANUFACTURING FACILITY over the next four years in conjunction with a plan to improve efficiency at the company's Pharmaceutical Division. Fisons plc announced the capital spending project on Jan. 25. Construction of the new facility is expected to begin in late 1994 at Fisons' principal manufacturing site, Holmes Chapel in Cheshire, England. Fisons will continue to manufacture asthma inhalers and several other anti-allergy pharmaceuticals at Holmes Chapel; the new facility will be designed to produce non-chlorofluorocarbon products.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth